Acquisition of the doctor-led “#1 At-Home Peel” brand continues Shiseido’s work to build its Americas business and strengthens its game in the dermocosmetics space, which has been growing fast since the pandemic. The firm’s net sales in the first nine months of 2023 increased 5% like-for-like to ¥722.4bn.
Shiseido Company, Ltd.’s planned acquisition of DDG Skincare Holdings LLC, owner of dermocosmetics brand Dr. Dennis Gross Skincare, will give it a strong position in the booming doctor-led skin care market and fuel growth of its Americas business, it says.
The Japanese company’s board of directors adopted a resolution for the transaction on 20 December, and on 22 December its...
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
